Why Focusing on Pain Killers is Imperative for Medical Device Startups: Interview with Daniel Hawkins, CEO of Shockwave Medical

Daniel Hawkins is the President and CEO of Shockwave Medical. He began his career in marketing and business development roles for Advanced Cardiovascular Systems, otherwise known as ACS, which is now part of Abbott Vascular. Following ACS, he held senior roles in general management, marketing, and business development with a number of private and public companies.

Daniel started the marketing department at Intuitive Surgical where he guided product feature development for the da Vinci Surgical Robot and developed key foundational marketing strategies for the company. He has also held senior leadership and/or founder roles with Endologix and Calibra Medical, which is now part of J&J. Daniel has an MBA from Stanford, a BS in economics from Wharton, and is a named inventor on over 100 patents and applications.

Interview Highlights with Daniel Hawkins

  • How his early upbringing gave rise to his entrepreneurial spirit.
  • Why focusing on pain killers is imperative for medtech startups.
  • Daniel’s early experiences at Intuitive Surgical and some of the most important lessons he learned commercializing the first surgical robot.
  • A question every medtech entrepreneur should ask themselves, “Does your product have natural pull?”
  • The importance of removing complexity and constraints when making key decisions.
  • How Daniel and his team came up with a concept for applying Lithotripsy to arterial plaque.
  • Daniel’s approach to raising money for Shockwave and how he was able to convince early investors during a tumultuous economic time.
  • Daniel’s favorite business book, the CEO he most admires, and what he’d tell his 30-year-old self.

Listen to the Interview with Daniel Hawkins

Read the Interview with Daniel Hawkins

Download a copy of the interview transcript right here.

You May Like These Articles

  • Recent
  • Featured
  • Related

How to Navigate Clinical Trials and Fundraising Challenges: Interview With Eyevensys CEO Patricia Zilliox

CEO of Eyevensys Patricia Zilliox gives her best advice for navigating drug and device development, including how to manage a long timeline in clinical trials, choosing an indication to design your device around, and why fundraising is the hardest part of her job.

From Investor Pitch to Eventual Partnership: Interview With HealthQuest Capital Founder Garheng Kong

HealthQuest Capital founder and managing partner Garheng Kong shares advice for entrepreneurs looking to fund their healthcare businesses. He discusses the value of a warm introduction, why some businesses aren’t a good fit for VC investors, and shares the sweet spot for syndication.

How To Launch Your Medical Device With a Global Perspective: Interview With Lightpoint Medical CEO Graeme Smith

Lightpoint Medical’s CEO, Graeme Smith, discusses strategies for medech commercial launches. He shares best practices for activating the key players when bringing new devices to market: payers, distributors, and investors.

Why Your Medical Device Company Needs Different Value Props For Different Stakeholders: Interview With Steve Anderson, Co-Founder and CEO of Preceptis Medical

Preceptis Medical CEO Steve Anderson explains how to keep all of your stakeholders in mind from the start, why having a voice of experience can help you navigate the process of getting to market, and why you should check and recheck your study protocols.

Conquering the Coverage and Reimbursement Landscape: Interview with Bruce Shook, President of Intact Vascular

In this interview, Bruce Shook discusses medical device insurance coverage and reimbursement, as well as advice for other healthcare entrepreneurs that need to raise money.

Why Curiosity and Persistence are Crucial Characteristics for Medtech Entrepreneurs: Interview with the Legendary Dr. John Simpson, Executive Chairman of Avinger

In this interview, the legendary Dr. John Simpson shares what drew him to the field of cardiology, his approach to building a medtech team, and why knowing your strengths and limitations is key to making a difference in the lives of others.

After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics

In this interview with Duke Rohen, he discusses how he successfully led two early-stage medtech companies at the same time and the major lessons he learned raising money for 4 different medical device companies.

Having a Heart Attack? There’s an App for That! The Incredible Story of How Dr. David Albert Brought the ECG iPhone App to Market

In this interview with Dr. David Albert, we learn about his incredible journey in bringing the first iPhone ECG app to market with AliveCor.

How to Navigate Clinical Trials and Fundraising Challenges: Interview With Eyevensys CEO Patricia Zilliox

CEO of Eyevensys Patricia Zilliox gives her best advice for navigating drug and device development, including how to manage a long timeline in clinical trials, choosing an indication to design your device around, and why fundraising is the hardest part of her job.

From Investor Pitch to Eventual Partnership: Interview With HealthQuest Capital Founder Garheng Kong

HealthQuest Capital founder and managing partner Garheng Kong shares advice for entrepreneurs looking to fund their healthcare businesses. He discusses the value of a warm introduction, why some businesses aren’t a good fit for VC investors, and shares the sweet spot for syndication.

How To Launch Your Medical Device With a Global Perspective: Interview With Lightpoint Medical CEO Graeme Smith

Lightpoint Medical’s CEO, Graeme Smith, discusses strategies for medech commercial launches. He shares best practices for activating the key players when bringing new devices to market: payers, distributors, and investors.

Why Your Medical Device Company Needs Different Value Props For Different Stakeholders: Interview With Steve Anderson, Co-Founder and CEO of Preceptis Medical

Preceptis Medical CEO Steve Anderson explains how to keep all of your stakeholders in mind from the start, why having a voice of experience can help you navigate the process of getting to market, and why you should check and recheck your study protocols.